Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



New Products

Related to Evaluation of Multiplex Immunoassay Results

    • Heterodimer Immunoassay Kit
    • Singulex
    • The Erenna® Interleuken-17A/F (IL-17A/F) heterodimer immunoassay kit is an addition to a suite of TH17 pathway bioassays which also includes IL-17A and IL-17F as well as several others. These biomarkers are members of the IL-17 signaling pathw
    • Immunoassay Slide
    • QuantiScientifics
    • The A²® Oligo-Link-it slide is designed for the development of multiplex immunoassays. The plastic slide contains arrays of capture oligonucleotides covalently linked to the surface. Antibodies can then be oligo-linked to complementary ol
    • Immunoassay Kits
    • PerkinElmer
    • Assay kits utilizing AlphaLISA® technology can aid in the safety testing, manufacturing, and quality control of biotherapeutic drugs. The kits can achieve high-quality results, which can help to accelerate the drug discovery process. AlphaLISA
    • Immunoassay System
    • Singulex
    • The Erenna® immunoassay system now benefits from a new high-definition single-molecule counting technology with which users can quantify previously undetectable biomarkers with LLoQ to femtogram levels, even in healthy populations. The system
    • Protein Biomarker Immunoassays
    • Olink Bioscience
    • Proseek® Multiplex is a generation of multiplexed protein biomarker immunoassays based on the Proximity Extension Assay (PEA) platform. Proseek Multiplex allows biomarker researchers to quantify 92 proteins in one microliter sample against a p
    • Antibody Arrays
    • R&D Systems
    • With Proteome Profiler Antibody Arrays, instead of performing multiple Western blots, users can start their experiments by profiling their lysates for up to 59 phospho-proteins in a single sample. Proteome Profiler Antibody Arrays can reveal relati
  • Page 1 of 1 (6 items) 1 

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll